gyrodyne_8k-020111.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported):  February 1, 2011
 

 
   
GYRODYNE COMPANY OF AMERICA, INC.
   
   
(Exact name of Registrant as Specified in its Charter)
   
         
New York   000-01684   11-1688021
(State or other jurisdiction   (Commission File    (I.R.S. Employer
of incorporation)   Number)   Identification No.)
         
   
ONE FLOWERFIELD
   
     SUITE 24    
   
ST. JAMES, NEW YORK 11780
   
   
(Address of principal executive offices) (Zip Code)
   
         
   
(631) 584-5400
   
   
Registrant’s telephone number, including area code
   
         
   
N/A
   
  (Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

Item 8.01.  Other Events

On February 1, 2011, the Court of Claims of the State of New York entered a decision and order (the “Order”) granting the motion of Gyrodyne Company of America, Inc. (the “Company”) for an additional allowance of $1,474,940.67 for actual and necessary costs, disbursements and expenses, including attorneys’ fees and expenses, incurred in its case for just compensation from the State of New York for land appropriated in 2005.  The additional allowance supplements the amount awarded by the Court in its decision in favor of the Company last year.  A copy of the Order is attached hereto as Exhibit 99.1.
 
Item 9.01.  Financial Statements and Exhibits
 
(d) Exhibits      
         
  Exhibit No.   Exhibit  
         
  99.1   Decision and Order  

 
 
 

 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
GYRODYNE COMPANY OF AMERICA, INC.
 
       
 
By:
/s/ Stephen V. Maroney  
   
Stephen V. Maroney
 
   
President and Chief Executive Officer
 
Date:  February 8, 2011